UK stocks got a healthy boost on Wednesday, led by a sharp rally in pharmaceutical giant AstraZeneca, while fresh housing data added to expectations that the Bank of England will cut interest rates next week.
AstraZeneca's shares jumped 7.24% after the company reported stronger-than-expected third-quarter profit. The drugmaker posted attributable profit of $3.12 billion, up from $2.53 billion in the same period last year. The company also kept its full-year outlook for mid-to-high single-digit revenue growth and a low double-digit rise in core earnings per share—a common profit measure that strips out certain one-off items.
The surge made AstraZeneca the biggest single contributor to the FTSE 100's gains, given its large weighting in the index. The blue-chip index rose as investors cheered the results from one of the UK's most valuable listed companies.
Housing data points to cooler market
Separately, data from Nationwide showed UK house price growth slowed to 0.5% in October 2026, down from the previous month's pace. The cooling in the housing market is seen as a sign that higher borrowing costs are beginning to weigh on demand, which could give the Bank of England more room to ease monetary policy.
Investors are now firmly focused on the Bank of England's policy decision next week. Markets have been building in the likelihood of a rate cut, and the softer housing data adds to the case for action. Lower interest rates typically reduce mortgage costs and can support consumer spending, which is why rate-sensitive sectors like housebuilders and retailers often react positively to such expectations.
BP also rises on profit jump
Energy giant BP also contributed to the FTSE 100's advance. The company reported quarterly attributable profit of $4.7 billion, up sharply from $1.16 billion a year earlier. The jump reflects higher energy prices and improved refining margins, though BP's shares rose more modestly than AstraZeneca's.
The strong corporate earnings from two of the index's heavyweight constituents helped offset broader concerns about the global economy. While company results, rather than macroeconomic data, did most of the work for UK stocks on the day, the housing figures kept rate-cut hopes alive.
What it means for investors
For everyday investors, the day's moves highlight how individual company results can move the entire market, especially when the company is as large as AstraZeneca. A single stock's earnings beat can lift the whole index, which is why diversification across sectors and regions remains a key principle for long-term investors.
The housing data also matters for anyone with a mortgage or considering buying a home. Slower house price growth could signal that the market is cooling, which might make properties more affordable over time. But it also reflects the impact of higher interest rates, which have made borrowing more expensive.
If the Bank of England cuts rates next week, mortgage rates could eventually fall, providing some relief to homeowners and potential buyers. However, rate cuts are not guaranteed, and the central bank will weigh inflation pressures against signs of economic weakness.
For those with savings, a rate cut would likely mean lower returns on cash deposits, prompting some investors to consider other options. But it's important to remember that all investments carry risk, and past performance is not a guide to future returns.
Investors will be watching the Bank of England's decision closely, along with any signals about the path of future rates. The coming weeks could also bring more corporate earnings reports, which will provide further clues about the health of UK businesses.
In the meantime, the FTSE 100's rise on the back of AstraZeneca and BP shows that company fundamentals still matter, even in a market driven by macroeconomic headlines.
